pmc logo image
Logo of brheartjJournal URL: http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=159&action=archive
Journal List > Br Heart J > v.41(3); Mar 1979

Formats:
Br Heart J. 1979 March; 41(3): 331–335.
PMCID: PMC482035
Copyright notice
Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.
R Davies, T G Pickering, A Morganti, M Wilson, and J H Laragh
Small right arrow pointing to: This article has been cited by other articles in PMC.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (739K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 331
331
icon of scanned page 332
332
icon of scanned page 333
333
icon of scanned page 334
334
icon of scanned page 335
335
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Birkenhäger WH, Krauss XH, Schalekamp MA, Kolsters G, Kroon BJ. Antihypertensive effects of propranolol. Observations on predictability. Folia Med Neerl. 1971;14(2):67–71. [PubMed]
  • Bravo EL, Tarazi RC, Dustan HP. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. N Engl J Med. 1975 Jan 9;292(2):66–70. [PubMed]
  • Bühler FR, Laragh JH, Baer L, Vaughan ED, Jr, Brunner HR. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med. 1972 Dec 14;287(24):1209–1214. [PubMed]
  • Castenfors J, Johnsson H, Orö L. Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta Med Scand. 1973 Mar;193(3):189–195. [PubMed]
  • Davies R, Slater JD, Rudolf M, Geddes DM. The effect of isoprenaline on plasma renin activity in man: a dose-response curve. Clin Endocrinol (Oxf). 1977 May;6(5):395–399. [PubMed]
  • Fitzgerald JD. Beta-blockade and mechanisms of disease. Postgrad Med J. 1976;52 (Suppl 4):184–190. [PubMed]
  • Frohlich ED, Tarazi RC, Dustan HP, Page IH. The paradox of beta-adrenergic blockade in hypertension. Circulation. 1968 Mar;37(3):417–423. [PubMed]
  • Hansson L, Zweifler AJ. The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension. Acta Med Scand. 1974 May;195(5):397–401. [PubMed]
  • Hollifield JW, Sherman K, Zwagg RV, Shand DG. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. N Engl J Med. 1976 Jul 8;295(2):68–73. [PubMed]
  • Leonetti G, Mayer G, Morganti A, Terzoli L, Zanchetti A, Bianchetti G, Di Salle E, Morselli PL, Chidsey CA. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl. 1975 Jun;48(6):491–499. [PubMed]
  • LeWinter MM, Crawford MH, Karliner JS, ORourke RA. Effects of oral propranolol in normal subjects. Clin Pharmacol Ther. 1975 Jun;17(6):709–712. [PubMed]
  • Michelakis AM, McAllister RG. The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab. 1972 Feb;34(2):386–394. [PubMed]
  • Miller RR, Olson HG, Pratt CM, Amsterdam EZ, Mason DT. Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):598–605. [PubMed]
  • Myers MG, Lewis PJ, Reid JL, Dollery CT. Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther. 1975 Feb;192(2):327–335. [PubMed]
  • Offerhaus L, van Zwieten PA. Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers. Cardiovasc Res. 1974 Jul;8(4):488–495. [PubMed]
  • Prichard BN. Propranolol as an antihypertensive agent. Am Heart J. 1970 Jan;79(1):128–133. [PubMed]
  • Prichard BN, Shinebourne E, Fleming J, Hamer J. Haemodynamic studies in hypertensive patients treated by oral proranolol. Br Heart J. 1970 Mar;32(2):236–240. [PubMed]
  • Sannerstedt R, Julius S, Conway J. Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation. 1970 Dec;42(6):1057–1064. [PubMed]
  • Sealey JE, Laragh JH. Radioimmunoassay of plasma renin activity. Semin Nucl Med. 1975 Apr;5(2):189–202. [PubMed]
  • Stokes GS, Weber MA, Thornell IR. Beta-blockers and plasma renin activity in hypertension. Br Med J. 1974 Jan 12;1(5897):60–62. [PubMed]
  • Stumpe KO, Kolloch R, Vetter H, Gramann W, Krück F, Ressel C, Higuchi M. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Am J Med. 1976 May 31;60(6):853–865. [PubMed]
  • Tarazi RC, Dustan HP. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. [PubMed]
  • Taylor SH, Davidson C, Singleton W, Thadani U. Proceedings: Comparison of antihypertensive effectiveness of beta-adrenoceptor antagonists with different pharmacological properties. Br Heart J. 1976 Mar;38(3):313–313. [PubMed]
  • Ulrych M, Franciosa J, Conway J. Comparison of a new beta adrenergic blocker (MK 950) and propranolol in man. Clin Pharmacol Ther. 1972 Mar–Apr;13(2):232–238. [PubMed]
  • Ulrych M, Frohlich ED, Dustan HP, Page IH. Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation. 1968 Mar;37(3):411–416. [PubMed]
Articles from British Heart Journal are provided here courtesy of
BMJ Group

PubMed articles by these authors